NAOV News and Press, NanoVibronix Inc. From 09/14/22

NanoVibronix, Inc . , (NASDAQ: NAOV) (the “Company”), announced today that its annual meeting of shareholders (the “Annual Meeting”) will take place at 10 a.m. Eastern time on December 15, 2022. The Company will hold the Annual Meeting virtually v...

NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that, on August 30, 2022, the Company received notice from the Nasdaq Listing Qualificatio...

NanoVibronix, Inc. , (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update in a letter to shareholders from its Chief Executive Officer, Brian M...

Educational Marketing Aimed at Expanding Product Awareness in Australia and New Zealand NanoVibronix, Inc. , (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announce...

Shifting Component of Manufacturing to Singapore NanoVibronix, Inc . (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it is shifting the majority of its man...

NanoVibronix press release (NASDAQ:NAOV): Q1 GAAP EPS of -$0.04. Revenue of $0.27M (+170.0% Y/Y). For further details see: NanoVibronix GAAP EPS of -$0.04, revenue of $0.27M

Expanded Distribution, Entry into New Geographic Markets and Regulatory Approvals Advancing Efforts Towards Full Commercialization NanoVibronix, Inc ., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acousti...

NanoVibronix (NASDAQ:NAOV) said it submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) seeking clearance of PainShield MD PLUS, an ultrasound pain therapy device. A 510(k) is a premarket submission made to the FDA to show that the device to be marketed is as saf...

NanoVibronix, Inc. (NASDAQ: NAOV) , a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration...

PainShield Plus and PainShield Monthly Kits Join UroShield and PainShield MD with Access to VA Market NanoVibronix, Inc. , (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SA...